Fig. 1From: Effects of the timing of administration of IgM- and IgA-enriched intravenous polyclonal immunoglobulins on the outcome of septic shock patientsFlowchart with inclusion and exclusion criteria. ivIgGAM, intravenous IgM- and IgA-enriched immunoglobulins; ICU intensive care unit; LOS length of stayBack to article page